SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TRUMP is a politics-themed digital coin built on the Solana blockchain that uses the brand of Donald Trump to foster a community-driven ecosystem. As a community-focused asset, it is designed to bridge political support with web ownership, operating within the PolitiFi sector to blend political movements with decentralized finance tools. The project's main value proposition lies in its official ties to Donald Trump’s media and business brands, which allows it to provide unique physical utility such as invitations to gala dinners and meetings at Mar-a-Lago.  The token serves as the primary currency for the officially licensed Trump Billionaires Club mobile and web game, where it is used for in-game purchases and unlocking features. By leveraging the Solana blockchain, the project ensures that these in-game actions and token transfers remain fast and cost-effective. The ecosystem remains stable through a programmatic release schedule that introduces new tokens slowly to prevent supply shocks, alongside the use of specialized market makers to maintain consistent liquidity for traders.  Holders can also participate in liquidity sharing by providing their tokens to automated systems to facilitate trading for others, often earning rewards or prizes in return. Beyond digital utility, holding a specific amount of the token is a requirement for attending exclusive real-world events, including VIP parties at Mar-a-Lago. The project is managed by the Trump Meme Team and is linked with Trump Media, with an investor base that includes a wide range of retail buyers and large holders who utilize secure custody services for their assets.

Trump For President

TRUMP is drawing attention over its steep decline and widespread claims that the meme coin has left retail holders with losses while Trump-linked insiders benefited; these are community allegations, not established here as fact. Traders are split between calling it a failed cash grab and speculating on a speculative rebound or short squeeze.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Rising crude prices amid Middle East tensions and supply-disruption fears are driving interest in Chevron and the broader energy sector. Traders are celebrating the stocks breakout and fresh highs, while some caution that the rally may be extended and closely tied to volatile oil headlines.

Select Sector SPDR Trust (The) - State Street Health Care Select Sector SPDR ETF

Health Care Select Sector SPDR Fund

Healthcare-sector strength and rotation into defensive names are driving attention, with traders highlighting XLVs breakout toward record highs and relative outperformance as technology weakens. The bullish view is tempered by concerns about a volatile, potentially extended rally and possible pullbacks; others see dips as buying opportunities.

iShares Trust - iShares 7-10 Year Treasury Bond ETF

iShares 7-10 Year Treasury Bond ETF

IEF is drawing attention amid concerns that persistent inflation, higher-for-longer rates and U.S. debt and borrowing pressures could keep Treasury yields elevated, weighing on bond prices. Traders are largely wary of further weakness, though some see a potential bond rebound if yields retreat.

Securitize Corp. is a financial technology company, which engages in the provision of regulated infrastructure for the issuance, management, trading, and administration of tokenized real-world assets (RWAs). The company was founded on October 17, 2025 and is headquartered in Miami, FL.

Securitize Corp.

Securitizes launch of tokenized U.S. stocks on Solana has fueled enthusiasm around its tokenization business, but the shares are now drawing attention for a sharp, volatile pullback. Bulls see the weakness as a buying opportunity and focus on long-term tokenization growth, while skeptics question revenue execution and the stocks erratic price action.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is drawing attention amid a sharp Nasdaq and tech selloff, with traders citing hotter inflation, weakness in AI and semiconductor stocks, and interest-rate concerns. The community is split between buying the dip and looking for an oversold bounce versus expecting bearish momentum to extend the decline.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

STRK is drawing attention around Starknets potential shift from an Ethereum Layer 2 to an independent, quantum-resistant Layer 1, alongside its privacy and Bitcoin DeFi themes. Traders are split between viewing these developments as support for a sharp rally and warning that recent volatility, profit-taking, and token-supply dilution could keep pressure on the price.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Helus Pharma is drawing attention ahead of the expected Q4 Phase 3 topline readout for HLP003, its investigational adjunctive treatment for major depressive disorder. Traders are divided between optimism based on earlier Phase 2 results and concern that the pivotal trial may disappoint, with the binary catalyst contributing to volatility and debate about financing risk.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is under pressure after disappointing earnings and a weaker bookings outlook intensified concerns about slowing growth, monetization and the impact of age-verification and child-safety changes. Bears point to analyst downgrades and execution risks, while bulls see the steep selloff as a buying opportunity given the platforms large user base.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

Hot inflation readings and elevated Treasury yields are fueling concerns about further Fed rate hikes, while traders debate whether the Dows relative resilience reflects a rotation into value and defensive stocks or whether weakness in tech and AI will spread across the broader market. The conversation is split between calls for a deeper pullback and views that the divergence is rotation rather than a market breakdown.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PAHC or LMAT: Which Is the Better Value Stock Right Now?

PAHC vs. LMAT: Which Stock Is the Better Value Option?

Reminder - LeMaitre Vascular (LMAT) Goes Ex-Dividend Soon

Looking at the universe of stocks we cover at Dividend Channel, on 8/20/26, LeMaitre Vascular Inc (Symbol: LMAT) will trade ex-dividend, for its quarterly dividend of $0.25, payable on 9/3/26. As a percentage of LMAT's recent stock price of $82.75, this dividend works out to ap...

GEHC or LMAT: Which Is the Better Value Stock Right Now?

GEHC vs. LMAT: Which Stock Is the Better Value Option?

LeMaitre Vascular (LMAT) Hit by Profit Taking

LeMaitre Vascular (LMAT) Hit by Profit Taking...

LeMaitre Vascular (LMAT) Q2 Earnings and Revenues Lag Estimates

LeMaitre (LMAT) delivered earnings and revenue surprises of -8.64% and -1.91%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Boston Scientific (BSX) Surpasses Q2 Earnings and Revenue Estimates

Boston Scientific (BSX) delivered earnings and revenue surprises of +3.61% and +1.07%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Casey's & 3 More Stocks With Strong Interest Coverage to Buy Now

CASY, CLS, PNTG and LMAT stand out for strong interest coverage as borrowing costs rise, with solid sales/EPS growth estimates and big one-year gains. 

LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why 

LeMaitre (LMAT) possesses solid growth attributes, which could help it handily outperform the market.

Down 17.2% in 4 Weeks, Here's Why LeMaitre (LMAT) Looks Ripe for a Turnaround 

LeMaitre (LMAT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

LeMaitre Vascular Enters Oversold Territory

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important...

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Lemaitre Vascular Inc

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$80.82
Prev Close	$83.16
Open	$82.53
Dividend Yield	0.99%
50-Day Moving Average	$80.92
Beta	0.72
Avg. Volume	263,331.35
PE Ratio	28.79

52-Week High	$118.01
52-Week Low	$78.22
Market Capitalization	$1.85B
EPS (Annual)	$2.52
Price to Book	4.40
Revenue Per Employee	$381,071.76

Feed

News

Sentiment

Earnings

Fundamentals

Info

LMAT Fundamentals